Arya Roy

Thank you to @stolaney1.bsky.social @dfcibreastonc.bsky.social for inviting me to give the J. Dirk Iglehart, M.D. Visiting Scholar Lecture at the DF/HCC Breast & Gynecologic Cancer Symposium.

Incredible science, great friends & connections - what an honor!

www.dfhcc.harvard.edu/events/dfhcc...

Honored and grateful for the opportunity to discuss 3 oral abstracts at #ASCO25 and represent #OSUCCC @osucccjames.bsky.social @osuwexmed.bsky.social #Immunotherapy @sitcancer.bsky.social #PIIO @ascocancer.bsky.social

Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team!
@OhioStateMedOnc
@OSUCCC_James
@OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social

Wonderful time giving grand rounds today at #Georgetown There’s nothing quite like going “home” to your alma mater and seeing all the amazing preceptors and mentors that so positively impacted your life #HoyaSaxa

@oncoalert.bsky.social annual #ASCO25 5K on a beautiful morning in Chicago! Had some great running partners this am @quirogad.bsky.social @christeeny513.bsky.social

Recognizing the brilliant #WomenInMedicine today 2/3/25 who continue to persevere, break glass ceilings and improve healthcare #NWPD25 #IamBlackwell @quirogad.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @maryamlustberg.bsky.social

Great session by Kevin Kalinsky of @emoryuniversity.bsky.social on overcoming endocrine resistance in ER+ #BreastCancer at the @osucccjames.bsky.social #SABCS Update

Join us 2/1/25 at the Hilton Columbus at Easton @osucccjames.bsky.social Update from the #SABCS24 👋Experts from #TheJames @mskcancercenter.bsky.social #Emory will address the latest insights and practical guidance presented at #SABCS24. Register here 👉 ccme.osu.edu/continuing-m...

Looking for your first faculty position? Or perhaps new start? THE Ohio State University Comprehensive Cancer Center (Columbus, OH) is hiring in several #MedOnc sections - GI, Thoracic, Breast, Neuroendocrine, cutaneous. #AcademicJobs #OSUCCC @osucccjames.bsky.social @christianrolfo.bsky.social

In this video @breastcancerdoc.bsky.social discusses the results of the phase III EMBER-3 trial of imlunestrant. She presented on this oral selective estrogen receptor degrader for #breastcancer treatment at #SABCS24.
ascopost.com/videos/2024-...

Divergent paths of mammary gland involution: unveiling the cellular dynamics in abruptly and gradually involuted mouse models - Breast Cancer Research Background Epidemiological studies associate an increase in breast cancer risk, particularly triple-negative breast cancer (TNBC), with lack of breastfeeding. This is more prevalent in African America...

What do we know about how the biology of mammary gland lactation and involution impact breast cancer risk?

Building on work from Dr. Pepper Schedin & many others, new work in #BreastCancerResearch from Ramaswamy Lab @osucccjames.bsky.social

link.springer.com/article/10.1...

America’s first bird flu death reported in Louisiana | CNN The first person to have a severe case of H5N1 bird flu in the United States has died, according to the Louisiana Department of Health.

BREAKING
#MedSky #IDSky #PublicHealth
The US has just reported our first death from #H5N1 #BirdFlu in #Louisiana.

CDC cautions the public (& their pets) about contact with sick/dead birds & their droppings, as well as raw (unpasteurized) eggs/dairy & undercooked meat.
www.cnn.com/2025/01/06/h...

Congratulations!!

#OncSky #MedEd

Arya Roy: Kicking off SABCS24 on a high note with the Coltman Scholar Award Notification - OncoDaily Arya Roy: Kicking off SABCS24 on a high note with the Coltman Scholar Award Notification / Arya Roy, cancer, Coltman Scholar Award, OncoDaily, Oncology, SABCS24

Kicking off SABCS24 on a high note with the Coltman Scholar Award Notification - Arya Roy

@sabcs.bsky.social
@aryaroy.bsky.social

oncodaily.com/blog/203597

#Cancer #ColtmanScholarAward #OncoDaily #Oncology #SABCS24 #Medicine #Health

Congrats to all the terrific team of Breast Cancer Section! Amazing group!
@drgattimays.bsky.social @stoverlab.bsky.social @quirogad.bsky.social @aryaroy.bsky.social @osuwexmed.bsky.social

So proud of new #OSU faculty member @aryaroy.bsky.social @osuwexmed.bsky.social #GoBucks @stoverlab.bsky.social @quirogad.bsky.social #GRASPAwardee

Our faculty @drgattimays.bsky.social & @quirogad.bsky.social & @aryaroy.bsky.social representing at #SABCS24!

@osuwexmed.bsky.social @osucccjames.bsky.social

The best #BreastOnc team in the country in my opinion 🥰 @osuwexmed.bsky.social @stoverlab.bsky.social @quirogad.bsky.social @aryaroy.bsky.social Love where you work

✨The best way to start the day at #SABCS24 is running the Riverwalk with @drgattimays.bsky.social @juliafoldimd.bsky.social @weoncologists.bsky.social

Thanks for organizing @oncoalert.bsky.social ! #OncoAlert

@aryaroy.bsky.social interviewing on behalf of @oncbrothers.bsky.social 🎙️ 🎬She did an amazing job!! 👏

Day 3 of #SABCS24 and some more great research from @osuwexmed.bsky.social faculty ##breastcancer @stoverlab.bsky.social @quirogad.bsky.social @aryaroy.bsky.social @sabcs.bsky.social

The @oncbrothers.bsky.social are discussing the adjuvant CDK4/6 inhibitor landscape, Drs @laurahuppert.bsky.social and @neil-iyengarmd.bsky.social agree shared decision making with patients in key. #SABCS24

Wonderful discussion by @drsgraff.bsky.social and Dr Giuseppe Curigilano on treatment of #Her2 #breastcancer @oncbrothers.bsky.social #bcsm #sabcs

Drs. @drsarahsammons.bsky.social and @drgattimays.bsky.social share pearls with @oncbrothers.bsky.social on managing early stage TNBC #SABCS24

Congratulations to Dr. Ali for presenting @swog.org 0221 results at @sabcs.bsky.social @oncoalert.bsky.social @clevelandclinic.bsky.social

Today I’m taking over #medsky and #instagram posts for @onclive.bsky.social Follow me for highlights and key takeaways from Day 3 of @sabcs.bsky.social
@osuwexmed.bsky.social #bcsm

Polygenic Risk Score (CRS) in Breast Cancer Risk Assessment

CRS predicted a different risk level than Tyrer-Cuzick (TC) for a substantial proportion of patients

CRS+ &/or TC+ received high-risk screening c/w guidelines for TC+ (recommendations for CRS+ do not exist) #SABCS24

Great real world case discussion including #OSU @stoverlab.bsky.social @osuwexmed.bsky.social on the use of liquid biopsies in #mBC treatment decisions @sabcs.bsky.social #SABCS24 #bcsm Take Away - not ready for broad use in all pts, but may help in specific cases and holds promise for future

Thank you very much Dan! @stoverlab.bsky.social